Clinical Trial Update: Safety and Tolerability Study of Drug to Treat Schizophrenia [Phase 2]

View source ↗

Summary

Phase 2 safety and tolerability trial results for a Sumitomo Pharma America, Inc. drug to treat schizophrenia have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• Drug to Treat Schizophrenia (Phase 2 study)

Snippet

Sponsor: Sumitomo Pharma America, Inc. | Conditions: Schizophrenia | Phase 2 | Status: COMPLETED | Results posted: 2011-05-19